Exane Derivatives’s Avantor AVTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.12K Hold
36
﹤0.01% 497
2022
Q1
$1.22K Hold
36
﹤0.01% 793
2021
Q4
$1.52K Hold
36
﹤0.01% 680
2021
Q3
$1.47K Hold
36
﹤0.01% 825
2021
Q2
$1.3K Sell
36
-5,048
-99% -$163K ﹤0.01% 851
2021
Q1
$147K Buy
5,084
+1,019
+25% +$29.4K 0.04% 341
2020
Q4
$114K Buy
+4,065
New +$105K 0.03% 382

Other funds holding AVTR

Exane Derivatives's AVTR Position: Q2 2022 in Review

Exane Derivatives held its Avantor (AVTR) position steady in Q2 2022 at 36 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #497.

Exane Derivatives first reported a position in AVTR in Q4 2020 and has held it in 7 quarters since. The position peaked at $147K in Q1 2021. 483 funds tracked by Wall St. Rank hold AVTR as of Q2 2022.

  • Exane Derivatives held 36 shares of Avantor worth $1.12K as of Q2 2022.
  • Exane Derivatives left its Avantor share count unchanged in Q2 2022.
  • Avantor made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #497 holding.
  • Exane Derivatives first reported a position in Avantor in Q4 2020 and has held it in 7 quarters since.
  • Exane Derivatives's Avantor position peaked at $147K in Q1 2021.
  • 483 funds tracked by Wall St. Rank held Avantor as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.